Status:
COMPLETED
The Clinical Investigation of a New Toothpaste Containing Stannous Fluoride as Compared to a Commercially Available Fluoride Toothpaste in Reducing Plaque and Gingivitis
Lead Sponsor:
Colgate Palmolive
Conditions:
Dental Plaque
Gingivitis
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The objective of this study is to evaluate the clinical efficacy of a new toothpaste containing stannous fluoride (SnF) as compared to Colgate Fluoride Toothpaste in reducing gingivitis and dental pla...
Detailed Description
This is a 6 month, take home, tooth brushing research study to evaluate a new toothpaste. Qualified subjects will be enrolled and randomized to either one of the two study groups based on their initi...
Eligibility Criteria
Inclusion
- Subjects, ages 18-70, inclusive.
- Availability for the six-month duration of the clinical research study.
- Good general health.
- Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
- Signed Informed Consent Form.
Exclusion
- Presence of orthodontic bands.
- Presence of partial removable dentures.
- Tumor(s) of the soft or hard tissues of the oral cavity.
- Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
- Five or more carious lesions requiring immediate restorative treatment.
- Antibiotic use any time during the one-month period prior to entry into the study.
- Participation in any other clinical study or test panel within the one month prior to entry into the study.
- Dental prophylaxis during the past two weeks prior to baseline examinations.
- History of allergies to oral care/personal care consumer products or their ingredients.
- On any prescription medicines that might interfere with the study outcome.
- An existing medical condition that prohibits eating or drinking for periods up to 4 hours.
- History of alcohol or drug abuse.
- Self-reported pregnant or lactating subjects.
Key Trial Info
Start Date :
May 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2017
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT03852056
Start Date
May 25 2017
End Date
December 7 2017
Last Update
February 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Dental Institute of Chengdu
Chengdu, Sichuan, China, 610041